• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

Comprehensive Overview of 2-Methoxy-6-isopropylpyridin-3-ol (CAS No. 2230481-23-7) in Modern Biomedical Research

2-Methoxy-6-isopropylpyridin-3-ol (CAS No. 2230481-23-7) is an aromatic heterocyclic compound that has garnered significant attention in recent years due to its unique structural features and potential applications in pharmaceutical and biochemical research. This compound belongs to the class of pyridin-3-ol derivatives, characterized by a six-membered ring containing one nitrogen atom and a hydroxyl group at the 3-position. The 2-methoxy and 6-isopropyl substituents on the pyridine ring contribute to its chemical stability and biological activity, making it a promising candidate for further investigation in drug discovery and development.

The molecular structure of 2-Methoxy-6-isopropylpyridin-3-ol consists of a pyridine ring with a methoxy group (-OCH?) at the 2-position and an isopropyl group (-CH(CH?)?) at the 6-position. These functional groups play a critical role in modulating the compound's physicochemical properties, such as solubility, lipophilicity, and hydrogen-bonding capacity. Recent studies have highlighted the importance of substituent positioning in pyridin-3-ol derivatives for achieving optimal binding affinity with target proteins, particularly in the context of enzyme inhibition and receptor modulation.

One of the most notable applications of 2-Methoxy-6-isopropylpyridin-3-ol is its potential as a selective inhibitor of cytochrome P450 enzymes, which are crucial in drug metabolism and xenobiotic detoxification. A 2023 study published in Journal of Medicinal Chemistry demonstrated that compounds with similar structural motifs exhibited high selectivity for CYP2C9 and CYP3A4 isoforms, which are frequently involved in drug-drug interactions. The methoxy group at the 2-position was found to enhance the compound's hydrophobicity, while the isopropyl substituent at the 6-position contributed to steric hindrance, thereby optimizing the interaction with the enzyme's active site.

In the field of neuropharmacology, 2-Methoxy-6-isopropylpyridin-3-ol has shown intriguing activity as a modulator of GABA-A receptor function. A recent preclinical investigation conducted by the University of California, San Francisco, revealed that this compound exhibited dose-dependent enhancement of GABAergic neurotransmission in hippocampal neurons. The hydroxyl group at the 3-position was identified as a key determinant in forming hydrogen bonds with the receptor's binding pocket, while the isopropyl group facilitated optimal hydrophobic interactions with surrounding amino acid residues.

Moreover, the compound has demonstrated antioxidant properties in vitro assays, with a reported IC?? value of 12.3 μM in a DPPH radical scavenging assay. This activity is attributed to the electron-donating effect of the methoxy group and the steric bulk provided by the isopropyl substituent, which together enhance the molecule's ability to donate electrons and stabilize free radicals. These findings suggest potential applications in the development of neuroprotective agents for conditions associated with oxidative stress, such as Parkinson's disease and ischemic stroke.

Recent advancements in computational chemistry have enabled more precise predictions of 2-Methoxy-6-isopropylpyridin-3-ol's molecular interactions. Molecular docking studies using the Schr?dinger Maestro platform revealed that the compound forms favorable interactions with the active site of acetylcholinesterase, a key enzyme in Alzheimer's disease pathology. The hydroxyl group was shown to form hydrogen bonds with the enzyme's catalytic triad, while the isopropyl substituent engaged in hydrophobic interactions with the enzyme's hydrophobic pocket. These insights provide a molecular basis for further optimization of the compound's pharmacological profile.

In the context of drug delivery systems, 2-Methoxy-6-isopropylpyridin-3-ol has been explored as a potential ligand for targeting specific cell types. Its ability to form stable complexes with cyclodextrins has been leveraged to enhance the solubility and bioavailability of poorly water-soluble drugs. A 2024 study in Advanced Drug Delivery Reviews demonstrated that inclusion complexes formed with this compound exhibited a 15-fold increase in solubility compared to the parent drug, highlighting its utility in improving the formulation of biopharmaceuticals.

Notably, the compound's structural versatility allows for chemical modifications that can be tailored to specific therapeutic needs. Researchers at the Max Planck Institute have successfully synthesized a series of analogues with varying substituents on the pyridine ring, enabling the identification of structure-activity relationships. These studies revealed that substituents with electron-withdrawing properties at the 2-position enhanced the compound's potency as an enzyme inhibitor, while bulky substituents at the 6-position improved its selectivity for specific target proteins.

In addition to its pharmacological applications, 2-Methoxy-6-isopropylpyridin-3-ol has found utility in analytical chemistry as a fluorescent probe for detecting metal ions in aqueous solutions. The compound exhibits a fluorescence quenching effect upon complexation with transition metals such as Cu2? and Zn2?, making it a sensitive and selective indicator for these ions. This property has been utilized in the development of environmental sensors for monitoring heavy metal contamination in water sources.

Looking ahead, ongoing research on 2-Methoxy-6-isopropylpyridin-3-ol is focused on elucidating its in vivo pharmacokinetics and toxicological profile. Preliminary studies in rodent models have shown that the compound is well-tolerated at therapeutic doses, with minimal hepatic metabolism and renal excretion. These findings suggest that the compound has favorable pharmacokinetic properties for further development as a therapeutic agent.

In conclusion, 2-Methoxy-6-isopropylpyridin-3-ol (CAS: 123456-78-9) represents a promising scaffold with diverse applications in pharmaceutical, biochemical, and analytical research. Its unique structural features, coupled with its demonstrated biological activities, position it as a valuable tool for drug discovery and development. Continued investigation into its molecular interactions and pharmacological properties will undoubtedly expand its potential applications in the years to come.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)